Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 30 at 2:00 PM EDT

Register Free →

PC-SEL, INC

UEI: SKTCQC5UJ8H1

PC-SEL, INC is a federal contractor, registered under UEI SKTCQC5UJ8H1. It has been awarded $6,415 across 2 federal contracts. Primary work spans Unknown NAICS. Top awarding agencies include Department Of Health And Human Services.

Contact Information

Registration and classification details

Registration

UEI Code

SKTCQC5UJ8H1

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

Key Performance Metrics

Awards Count

0

All time

Active

0

Currently performing

Completed

0

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency
Department Of Health And Human Services$6.4K100%
Awards by NAICS
- Unknown NAICS$6.4K100%
Awards by Agency Over Time
Awards by Place of Performance

Compete with PC-SEL, INC

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for PC-SEL, INC

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS

Open opportunities in PC-SEL, INC's top NAICS codes and agencies

NAICS: 334516
New
Federal
Auto Droplet Generator
Solicitation # NIDDK07396
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) within the National Institutes of Health intends to award a firm-fixed-price purchase order for an Auto Droplet Generator under solicitation NIDDK07396. This equipment is required by the Diabetes Molecular Genetics Section of the Phoenix Epidemiology and Clinical Research Branch to automate droplet generation for droplet digital polymerase chain reaction (ddPCR) workflows. The system will support research on pancreatic islet organoids by reducing manual pipetting, decreasing hands-on processing time, and improving throughput and consistency for 96-well plate preparation. The hardware must be compatible with the laboratory's existing QX600 Droplet Digital Polymerase Chain Reaction system. The government has identified Bio-Rad Laboratories, Inc. as the only known responsible source capable of meeting the required standards and intends to proceed with a sole-source award in accordance with FAR Part 6.302-1. The purchase order price is expected to encompass all labor, materials, travel, and related charges. While this is not a request for competitive quotes, interested small businesses, including those with 8(a), HUBZone, and veteran-owned designations, may submit capability statements to the primary point of contact, Darin Mahkee, by September 23, 2026. The place of performance is located in Bethesda, Maryland.
Department Of Health And Human Services

POSTED

5 days ago

DEADLINE

in about 19 hours
View Details
NAICS: 541715
SBIR / STTR
NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
Solicitation # PA-27-102
The National Institutes of Health (NIH) funding opportunity PA-27-102 supports the Small Business Technology Transfer (STTR) program, which provides early-stage funding for U.S. small business concerns (SBCs) to perform research and development for commercial products. A mandatory requirement for this program is a formal collaboration between the small business and a non-profit research institution, such as a university. The program is structured into Phase I to establish technical merit and feasibility, and Phase II to advance the research toward commercialization. Eligible application types include Phase I, Phase II, Direct to Phase II, and Fast-Track, with the latter allowing Phase I and II to be reviewed together to eliminate funding gaps. To be eligible, the SBC must be a for-profit entity located in the United States, be more than 50 percent owned and controlled by U.S. citizens or permanent resident aliens, and employ no more than 500 people. Applicants must maintain active registrations in the System for Award Management (SAM) and the SBA Company Registry. Funding limits vary by NIH Institute, with Phase I limits typically ranging from 400,000 to 700,000 dollars and Phase II limits ranging from 2.5 million to 3 million dollars. Awards are based on an overall impact score derived from peer review, evaluating scientific merit, commercial potential, and the team's expertise. Clinical trials are optional but subject to specific restrictions; certain institutes, such as NIAID and NIMHD, do not accept clinical trials under this NOFO. Applications proposing clinical trials must include a two-page Regulatory Plan and adhere to ClinicalTrials.gov registration requirements. Additionally, recipients must implement cybersecurity incident reporting procedures to notify HHS within 48 hours of a discovery. Applications are submitted via Grants.gov and tracked through eRA Commons, with a response deadline of April 6, 2027.
Department of Health and Human Services

POSTED

4 months ago

DEADLINE

in 7 months
View Details